The activity of the insulin-stimulated AMP-activated protein kinase (AMPK) and GLUT4 transporter are downregulated in patients with obesity and T2DM with the selective inactivation of its gene impairing insulin-dependent adipose glucose disposal leading to T2DM (86, 97–99). This evidence concerns the gene INS and Obesity.